Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-01-14, Stock:JNJ, The news for the past five days is as follows:
2020-01-07: NEWS1: Dow Jones Today: Middle East Focus Factors Into The Equation Again.NEWS2: Ignore the Analysts: Johnson & Johnson Faces Serious Legal Liability.NEWS3: JNJ Stock Is Technically Inside A Buy Zone — Is It Time To Buy Shares?.NEWS4: Protagonist (PTGX) Starts Study on PTG-300 for Blood Disorder.
2020-01-08: NEWS1: Jabil Inc. -- Moody's rates Jabil's new notes Baa3, outlook stable.NEWS2: Pacira's (PCRX) Exparel Meets Key Goals in C-Section Study.NEWS3: This Medical Giant Tried To Break Out — Should You Buy ABT Stock Now?.NEWS4: 3 Pharma & Biotech Pipeline Areas to Keep an Eye on in 2020.NEWS5: Cambridge startup bringing AI to drug development raises $60M.
2020-01-09: NEWS1: Johnson & Johnson (JNJ) Gains But Lags Market: What You Should Know.NEWS2: 4 Things to Pay Attention to at the J.P. Morgan Health-Care Conference Next Week.NEWS3: Johnson & Johnson spinout signs licensing, collaboration deal worth up to $1.4B.
2020-01-10: NEWS1: Government experts urge new talc testing standards amid asbestos worries.NEWS2: California may become first state to sell its own prescription drugs.NEWS3: Harold Burson, PR legend, dies at 98.NEWS4: Should Investors Buy Johnson & Johnson Stock Prior to Earnings?.NEWS5: 7 Healthcare Stocks to Buy or Sell As Pricing Pressures Mount.NEWS6: Dow Heads Toward 29,000: Grab 5 Blue-Chip Stocks Now.
2020-01-13: NEWS1: Why Johnson & Johnson (JNJ) Could Beat Earnings Estimates Again.NEWS2: New Study Could Clear Johnson & Johnson on Talc, but Is It a Buy Signal?.NEWS3: Glaxo Files Marketing Application for Fostemsavir in Europe.NEWS4: The Zacks Analyst Blog Highlights: JPMorgan Chase, Johnson & Johnson, American Express Company, NIKE and Apple.NEWS5: Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?.

Answer: Rise